Literature DB >> 20636673

Patients' perceptions and illness severity at start of antidepressant treatment in general practice.

Erica C G van Geffen1, Eiebert R Heerdink, Jacqueline G Hugtenburg, Frans W Siero, Antoine C G Egberts, Rolf van Hulten.   

Abstract

OBJECTIVES: Patients' perceptions are important to consider when trying to understand why patients often do not follow prescriptions for antidepressant treatment. This study aimed to investigate the influence of patients' perceptions and illness severity at the start on antidepressant-medication-taking behaviour.
METHODS: Eighteen community pharmacies in the Netherlands participated in this 6-month follow-up study. One hundred and ten patients presenting a first antidepressant prescription, prescribed by a general practitioner (GP), were included. A questionnaire was completed at inclusion, after 6 and 26 weeks. KEY
FINDINGS: Of all 110 patients, eight (7.3%) did not initiate drug taking, 32 (29.1%) discontinued use, six (5.5%) switched to different antidepressant medication, and 64 (58.2%) continued on the same antidepressant during follow-up. Compared to continuers, non-initiators had lower belief scores for impact of illness (P = 0.044), perceived norm GP (P < 0.001), intention to take medication (P < 0.001), and attitude towards medication (P = 0.004). Furthermore, non-initiators were less severely depressed (P = 0.024). Discontinuers and continuers did not differ in illness severity at inclusion. However, discontinuers more often reported a non-specific reason for use, such as fatigue and sleeping problems (P = 0.014). Compared to continuers, switchers had higher illness severity scores at inclusion (depression, P = 0.041; anxiety, P = 0.050). During follow-up depression and anxiety severity improved for all treatment groups and reached the same level of severity at 6 months.
CONCLUSIONS: Patients' illness and treatment perceptions and illness severity influence their decisions about antidepressant drug taking. Patients' care could be improved by eliciting patients' beliefs about illness and treatment and assessing illness severity before prescribing.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20636673     DOI: 10.1111/j.2042-7174.2010.00035.x

Source DB:  PubMed          Journal:  Int J Pharm Pract        ISSN: 0961-7671


  6 in total

1.  Why underserved patients do not consult their general practitioner for depression: results of a qualitative and a quantitative survey at a free outpatient clinic in Paris, France.

Authors:  Claire Rondet; Isabelle Parizot; Jean Sebastien Cadwallader; Jacques Lebas; Pierre Chauvin
Journal:  BMC Fam Pract       Date:  2015-05-08       Impact factor: 2.497

Review 2.  Understanding patients' adherence-related beliefs about medicines prescribed for long-term conditions: a meta-analytic review of the Necessity-Concerns Framework.

Authors:  Rob Horne; Sarah C E Chapman; Rhian Parham; Nick Freemantle; Alastair Forbes; Vanessa Cooper
Journal:  PLoS One       Date:  2013-12-02       Impact factor: 3.240

3.  Effectiveness and cost-effectiveness of a multicomponent intervention to improve medication adherence in people with depressive disorders - MAPDep: a study protocol for a cluster randomized controlled trial.

Authors:  Tasmania Del Pino-Sedeño; Wenceslao Peñate; Carlos de Las Cuevas; Cristina Valcarcel-Nazco; Ascensión Fumero; Pedro Guillermo Serrano-Pérez; Francisco Javier Acosta Artiles; Vanesa Ramos García; Beatriz León Salas; Daniel Bejarano-Quisoboni; María M Trujillo-Martín
Journal:  Patient Prefer Adherence       Date:  2019-02-22       Impact factor: 2.711

4.  Initiation and Single Dispensing in Cardiovascular and Insulin Medications: Prevalence and Explanatory Factors.

Authors:  Carles Vilaplana-Carnerero; Ignacio Aznar-Lou; María Teresa Peñarrubia-María; Antoni Serrano-Blanco; Rita Fernández-Vergel; Dolors Petitbò-Antúnez; Montserrat Gil-Girbau; Marian March-Pujol; Juan Manuel Mendive; Alba Sánchez-Viñas; Cristina Carbonell-Duacastella; Maria Rubio-Valera
Journal:  Int J Environ Res Public Health       Date:  2020-05-12       Impact factor: 3.390

5.  Methylphenidate augmentation of escitalopram to enhance adherence to antidepressant treatment: a pilot randomized controlled trial.

Authors:  Martin P Paulus; Rayus Kuplicki; Teresa A Victor; Hung-Wen Yeh; Sahib S Khalsa
Journal:  BMC Psychiatry       Date:  2021-11-19       Impact factor: 3.630

6.  An Active Inference Approach to Dissecting Reasons for Nonadherence to Antidepressants.

Authors:  Ryan Smith; Sahib S Khalsa; Martin P Paulus
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2019-12-05
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.